NCT07463976 2026-04-13
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
Not yet recruiting
Clinical Trials
32 trialsNCT04433156 2026-04-09
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Phase 2 Completed
NCT07505849 2026-04-01
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT07503353 2026-03-31
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Not yet recruiting
NCT06971848 2026-03-30
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT07502118 2026-03-30
NexCAR19
Health Institutes of Turkey
Phase 2/3 Recruiting
NCT07457112 2026-03-09
EHCancer
Zagazig University
Phase NA Completed
NCT07451743 2026-03-05
ACL ALL
ASL Lecce
Phase NA Not yet recruiting
NCT05340686 2026-02-10
Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
Region Stockholm
Phase NA Suspended
NCT06114498 2026-01-23
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
National Medical Research Center for Therapy and Preventive Medicine
Active not recruiting
NCT07211048 2026-01-21
Anti CD19 Gene Therapy for B-cell Lymphoma
Anhui Provincial Hospital
Phase NA Recruiting
NCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
NCT06421948 2025-12-05
Linperlisib Combined With Chidamide in Patients With PTCL
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT06520163 2025-12-04
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT05083208 2025-12-02
PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma
Henan Cancer Hospital
Phase 1 Terminated
NCT07258043 2025-12-02
EPOCH
Hospital General de Mexico
Recruiting
NCT04214626 2025-11-19
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
Phase 2 Completed
NCT07233720 2025-11-18
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Recruiting
NCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT07191249 2025-09-24
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
Tel-Aviv Sourasky Medical Center
Phase 2 Not yet recruiting
NCT06026046 2025-09-19
EscrimHEMA
University Hospital, Angers
Phase NA Active not recruiting
NCT07176130 2025-09-16
Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
Singapore National Eye Centre
Active not recruiting
NCT06832683 2025-09-10
Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance Imaging
Kocaeli City Hospital
Phase NA Completed
NCT07162571 2025-09-09
MSTH-CAR002
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Not yet recruiting
NCT07134504 2025-08-21
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
Completed
NCT06944119 2025-07-28
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Tel-Aviv Sourasky Medical Center
Active not recruiting
NCT06795815 2025-06-12
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT06793410 2025-06-05
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Vastra Gotaland Region
Phase 2 Recruiting
NCT06961669 2025-05-29
ECAR01
Anhui Provincial Hospital
Phase NA Recruiting
NCT06964841 2025-05-09
PRIMARY TESTICULAR LYMPHOMA
Instituto Mexicano del Seguro Social
Completed
NCT04668365 2025-04-25
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
Phase 2 Suspended
NCT04263935 2025-04-23
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Henan Cancer Hospital
Recruiting